Bobby V. Khan
8Patents
6h-index
7Co-inventors
52Inventor score
Filing activity: Oct 4, 1994 → May 14, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5846959A | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases | Emerging Cross-Sectional Technologies | 28 | Expired |
| US5811449A | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases | Emerging Cross-Sectional Technologies | 27 | Expired |
| US5750351A | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases | Emerging Cross-Sectional Technologies | 25 | Expired |
| US5773209A | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases | Emerging Cross-Sectional Technologies | 24 | Expired |
| US5807884A | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases | Emerging Cross-Sectional Technologies | 19 | Expired |
| US5773231A | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases | Emerging Cross-Sectional Technologies | 19 | Expired |
| US9012492B2 | Apocynin-lipoic acid conjugates and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10456391B2 | Compositions and methods for treating cardiometabolic diseases and disorders | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.